The Immuno-Oncology-Microbiome (IOM) axis is a tripartite regulatory system involving microbiota, immune cells, and tumors, which critically modulates cancer progression and therapy response. This systematic review synthesizes key advances from 2022 to 2025, illustrating the field’s evolution from macro-associations to...
Yi-Mao Wu, Fei-Yang Tang, G. Zengin et al.· The Innovation Oncology· 0 citations
This review traces the evolution of nanomedicine from a passive drug delivery vehicle to a therapeutic program encoded in a physical structure, and examines the design constraints that will determine whether the next generation of cancer nanomedicines fulfills its clinical promise.
Yi-Mao Wu, Fei-Yang Tang, Junying Lee et al.· Biomaterials· 0 citations
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including c...